Global Budesonide Competitive Landscape Professional Research Report 2024
Description
Global Budesonide Competitive Landscape Professional Research Report 2024
Research Summary
Budesonide is a synthetic corticosteroid medication used primarily for its anti-inflammatory properties. It belongs to a class of drugs known as glucocorticoids and is commonly prescribed for the treatment of various inflammatory conditions, particularly those affecting the respiratory system. Budesonide can be administered in different forms, including inhalers for asthma and chronic obstructive pulmonary disease (COPD), nasal sprays for allergic rhinitis, and oral formulations for inflammatory bowel diseases like Crohn＇s disease and ulcerative colitis. By reducing inflammation and suppressing the immune response, budesonide helps to alleviate symptoms such as wheezing, nasal congestion, and bowel inflammation. It is known for its targeted action, as it primarily acts locally in the affected area while minimizing systemic side effects often associated with corticosteroids. Budesonide is available by prescription and should be used under the guidance of a healthcare professional.
According to DIResearch's in-depth investigation and research, the global Budesonide market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.
The major global manufacturers of Budesonide include AstraZeneca, Teva, Mylan, Sandoz, Cosmo Pharmaceuticals, Salix, Chiesi Farmaceutici, Orion Corporation, Cipla, Synmosa Biopharma, Lunan Better Pharma, Shanghai Sine Promod etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Budesonide. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Budesonide market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Budesonide market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Budesonide industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Budesonide Include:
AstraZeneca
Teva
Mylan
Sandoz
Cosmo Pharmaceuticals
Salix
Chiesi Farmaceutici
Orion Corporation
Cipla
Synmosa Biopharma
Lunan Better Pharma
Shanghai Sine Promod
Budesonide Product Segment Include:
Injectable Suspension
Aerosols
Inhalation Powder
Tablet and Capsule
Budesonide Product Application Include:
di_application
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Budesonide Industry PESTEL Analysis
Chapter 3: Global Budesonide Industry Porter’s Five Forces Analysis
Chapter 4: Global Budesonide Major Regional Market Size and Forecast Analysis
Chapter 5: Global Budesonide Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Budesonide Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Budesonide Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Budesonide Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Budesonide Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Budesonide Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Budesonide Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Budesonide Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents
170 Pages
- 1 Budesonide Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Budesonide Product by Type
- 1.2.1 Global Budesonide Market Size by Type, 2023 VS 2024 VS 2030
- 1.2.2 Injectable Suspension
- 1.2.3 Aerosols
- 1.2.4 Inhalation Powder
- 1.2.5 Tablet and Capsule
- 1.3 Budesonide Product by Application
- 1.3.1 Global Budesonide Market Size by Application, 2023 VS 2024 VS 2030
- 1.3.2 di_application
- 1.4 Global Budesonide Market Revenue Analysis (2019-2030)
- 1.5 Budesonide Market Development Status and Trends
- 1.5.1 Budesonide Industry Development Status Analysis
- 1.5.2 Budesonide Industry Development Trends Analysis
- 2 Budesonide Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Budesonide Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Budesonide Market Analysis by Regions
- 4.1 Budesonide Overall Market: 2023 VS 2024 VS 2030
- 4.2 Global Budesonide Revenue and Forecast Analysis (2019-2030)
- 4.2.1 Global Budesonide Revenue and Market Share by Region (2019-2024)
- 4.2.2 Global Budesonide Revenue Forecast by Region (2025-2030)
- 5 Global Budesonide Market Size by Type and Application
- 5.1 Global Budesonide Market Size by Type
- 5.2 Global Budesonide Market Size by Application
- 6 North America
- 6.1 North America Budesonide Market Size and Growth Rate Analysis (2019-2030)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Budesonide Market Size by Type
- 6.4 North America Budesonide Market Size by Application
- 6.5 North America Budesonide Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Budesonide Market Size and Growth Rate Analysis (2019-2030)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Budesonide Market Size by Type
- 7.4 Europe Budesonide Market Size by Application
- 7.5 Europe Budesonide Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Budesonide Market Size and Growth Rate Analysis (2019-2030)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Budesonide Market Size by Type
- 8.4 China Budesonide Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Budesonide Market Size and Growth Rate Analysis (2019-2030)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Budesonide Market Size by Type
- 9.4 APAC (excl. China) Budesonide Market Size by Application
- 9.5 APAC (excl. China) Budesonide Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Indonesia
- 9.5.6 Vietnam
- 9.5.7 Malaysia
- 9.5.8 Thailand
- 10 Latin America
- 10.1 Latin America Budesonide Market Size and Growth Rate Analysis (2019-2030)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Budesonide Market Size by Type
- 10.4 Latin America Budesonide Market Size by Application
- 10.5 Latin America Budesonide Market Size by Country
- 10.5.1 Mecixo
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Budesonide Market Size and Growth Rate Analysis (2019-2030)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Budesonide Market Size by Type
- 11.4 Middle East & Africa Budesonide Market Size by Application
- 11.5 Middle East & Africa Budesonide Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Market Competition by Manufacturers
- 12.1 Global Budesonide Market Revenue by Key Manufacturers (2020-2024)
- 12.2 Budesonide Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Budesonide Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 AstraZeneca
- 13.1.1 AstraZeneca Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 AstraZeneca Budesonide Product Portfolio
- 13.1.3 AstraZeneca Budesonide Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.2 Teva
- 13.2.1 Teva Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Teva Budesonide Product Portfolio
- 13.2.3 Teva Budesonide Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.3 Mylan
- 13.3.1 Mylan Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Mylan Budesonide Product Portfolio
- 13.3.3 Mylan Budesonide Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.4 Sandoz
- 13.4.1 Sandoz Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Sandoz Budesonide Product Portfolio
- 13.4.3 Sandoz Budesonide Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.5 Cosmo Pharmaceuticals
- 13.5.1 Cosmo Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Cosmo Pharmaceuticals Budesonide Product Portfolio
- 13.5.3 Cosmo Pharmaceuticals Budesonide Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.6 Salix
- 13.6.1 Salix Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Salix Budesonide Product Portfolio
- 13.6.3 Salix Budesonide Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.7 Chiesi Farmaceutici
- 13.7.1 Chiesi Farmaceutici Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Chiesi Farmaceutici Budesonide Product Portfolio
- 13.7.3 Chiesi Farmaceutici Budesonide Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.8 Orion Corporation
- 13.8.1 Orion Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 Orion Corporation Budesonide Product Portfolio
- 13.8.3 Orion Corporation Budesonide Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.9 Cipla
- 13.9.1 Cipla Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Cipla Budesonide Product Portfolio
- 13.9.3 Cipla Budesonide Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.10 Synmosa Biopharma
- 13.10.1 Synmosa Biopharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Synmosa Biopharma Budesonide Product Portfolio
- 13.10.3 Synmosa Biopharma Budesonide Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.11 Lunan Better Pharma
- 13.11.1 Lunan Better Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 Lunan Better Pharma Budesonide Product Portfolio
- 13.11.3 Lunan Better Pharma Budesonide Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.12 Shanghai Sine Promod
- 13.12.1 Shanghai Sine Promod Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.12.2 Shanghai Sine Promod Budesonide Product Portfolio
- 13.12.3 Shanghai Sine Promod Budesonide Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 14 Industry Chain Analysis
- 14.1 Budesonide Industry Chain Analysis
- 14.2 Budesonide Industry Raw Material and Suppliers Analysis
- 14.2.1 Upstream Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Budesonide Typical Downstream Customers
- 14.4 Budesonide Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
